The North America Teledermatology Market would witness market growth of 13.9% CAGR during the forecast period (2023-2030).
Teledermatology is a subcategory of dermatology and one of the most widespread applications of e-health and telemedicine. While using telemedicine, tele-dermatologists make diagnoses and determine the optimal treatment plan for a patient. Instead of seeing patients in person, they utilize aural, visual, and data instruments for telecommunications. The practice of teledermatology (as telemedicine) is centered on two concepts, namely store-and-forward (SAF) and real-time or interactive teledermatology. It is also possible to combine SAF and real-time application methods to create hybrid modalities of data transmission.
Moreover, teledermatology services are frequently viewed as more cost-effective than hospital and clinic visits. It negates the need for in-person visits, saving patients money on travel and time away from work. In addition, the accelerated development and adoption of digital health infrastructure, such as electronic health records (EHRs) and secure communication platforms, has facilitated the incorporation of teledermatology into existing healthcare systems. This interoperability enables dermatologists and other healthcare providers to communicate and share information seamlessly. The rise in patient preference for remote care and improved access to healthcare primarily drives the growth of the market.
Healthcare facilities in the United States have established eHealth systems and are implementing telemedicine to allow physicians to visit outpatients at their homes. These telemedicine and eHealth platforms are undeniably essential to the dermatology industry. Since the 1997 federal budget, the Canadian government has invested in eHealth, including federal commitments via First Ministers' Agreements. The government's commitment to collaboration significantly contributes to its work's success. In addition, Health Canada's priorities and efforts have been focused on addressing the issues and concerns about policy associated with mainstreaming eHealth services into the nation's healthcare system and monitoring the deployment and financial investment in these services. All of these factors are expected to contribute to the growth of telehealth adoption, and the dermatology market will not be an exception. Consequently, the demand is anticipated to expand in the region.
The US market dominated the North America Teledermatology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7,523.2 million by 2030. The Canada market is experiencing a CAGR of 16.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 15.5% during (2023 - 2030).
Based on Type, the market is segmented into Services and Product. Based on Services Type, the market is segmented into Teleconsultation, Telemonitoring and Tele-education. Based on Modality, the market is segmented into Store-and-forward (Asynchronous) and Real-time (Synchronous). Based on End User, the market is segmented into Homecare and Healthcare Units. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Teledermatology Market is Projected to reach USD 27.7 Billion by 2030, at a CAGR of 15.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ksyos, MetaOptima Technology, Inc., Veradigm, Inc., McKesson Corporation, Teladoc Health, Inc., FirstDerm, 3M Company (3M Health Information Systems), Siemens Healthineers AG (Siemens AG), DermUtopia and Digital Diagnostics, Inc. (3Derm Systems, Inc.).
By Type
By Modality
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
